Replies to post #49 on Shizane's Accounts

[Shizane]

NVAX - Currently Holding

Novavax, Inc. has a very interesting week.

Beginning on Wednesday, September 11, 2013 NVAX will present at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colorado the session, entitled “RSV F Protein Vaccine Is Well-Tolerated and Immunogenic in Elders,” will present data from the company’s recently completed Phase 1 clinical trial of its RSV vaccine candidate in healthy elderly adults. Also, on the 11th “Passive Immunization with RSV F Vaccine-Induced Polyclonal Antibodies Protect Cotton Rats from RSV A Challenge" will be presented, both sessions are scheduled to be presented from 11:00AM - 01:00PM.

Then on Thursday, September 12, 2013 President and CEO of NVAX Stanley C. Erck will present at the Stifel Nicolaus Healthcare Conference 2013 in Boston, Massachusetts @ 09:45AM.


Links for more information on the presentations.
Novavax, Inc. Events

[Shizane]

SOLD: NVAX

Sold NVAX at $3.36 for a 2.36% gain will keep an eye on the stock as in nears the "Analyst Day" on September 24, 2013.